Paying the Price for Beauty Abroad: Khoula Hospital’s experience with complications following aesthetic procedures performed overseas, 2013–2023
Sultan Qaboos University Medical Journal · 07.02.2026 · 26 (1) · 121-128
DOI: 10.18295/2075-0528.2965 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sultan Qaboos University Medical Journal, online erschienen am 07.02.2026. Verfasst von Khalifa Al Alawi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic & Reconstructive Surgery, Hamad Medical Corporation, Doha, Qatar. Hauptthemen laut MEDLINE: Postoperative Complications, Plastic Surgery Procedures, Medical Tourism. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Objective
This study aimed to evaluate the types and outcomes of complications arising from aesthetic surgeries performed abroad and subsequently managed at Khoula Hospital, Muscat, Oman.
Methods
This retrospective study included patients who presented with post-aesthetic surgical complications after undergoing procedures outside Oman from January 2013 to December 2023. Data were extracted from Khoula Hospital’s electronic health records, focusing on demographics, procedures performed, types of complications and outcomes, including admissions and surgical interventions.
Results
A total of 191 patients with 488 recorded encounters were included. The most common procedures done overseas were abdominoplasty (50.8%), lipectomy (29.3%) and breast surgeries (17.8%); Iran was the most frequent destination (60.7%). The predominant complications included wound infections with gapping (36.1%), seromas (20.4%), cellulitis (11.0%) and abscesses (5.8%). Severe cases required intensive care unit admission, reconstructive surgeries or prolonged length hospital stay. Nearly half of the admitted patients required surgical intervention with 20.0% necessitating critical care.
Conclusion
Aesthetic tourism poses substantial risks, with infections and wound complications being the most common postoperative issue. These findings highlight the need for public education, improved regulation and stronger follow-up systems to minimise adverse outcomes and reduce the hidden burden on the local healthcare system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic & Reconstructive Surgery, Hamad Medical Corporation, Doha, Qatar.
- Department of Plastic & Reconstructive Surgery, Khoula Hospital, Muscat, Oman.
ORCID-Profile: Khalifa Al Alawi, Areej Al-Mamari, Maysa Al-Maawali, Ashima Alkabi, Al-Batul Al-Mufargi, Juhaina Al Tobi, Hoor Al-Khanjari, Yasmine Al Balushi, Rawan Al Mandhari, Rafal Aljadder, Sultan Al Shaqsi
Zitieren
APA
Al Alawi, K., Al-Mamari, A., Al-Maawali, M., Alkabi, A., Al-Mufargi, A. B., Al Tobi, J., Al-Khanjari, H., Al Balushi, Y., Al Mandhari, R., Aljadder, R., & Al Shaqsi, S. (2026). Paying the Price for Beauty Abroad: Khoula Hospital’s experience with complications following aesthetic procedures performed overseas, 2013–2023. Sultan Qaboos University Medical Journal, 26(1), 121-128. https://doi.org/10.18295/2075-0528.2965
Vancouver
Al Alawi K, Al-Mamari A, Al-Maawali M, Alkabi A, Al-Mufargi AB, Al Tobi J, et al. Paying the Price for Beauty Abroad: Khoula Hospital’s experience with complications following aesthetic procedures performed overseas, 2013–2023. Sultan Qaboos University Medical Journal. 2026;26(1):121-128. doi:10.18295/2075-0528.2965
BibTeX
@article{AlAlawi2026,
author = {Al Alawi, Khalifa and Al-Mamari, Areej and Al-Maawali, Maysa and Alkabi, Ashima and Al-Mufargi, Al-Batul and Al Tobi, Juhaina and Al-Khanjari, Hoor and Al Balushi, Yasmine and Al Mandhari, Rawan and Aljadder, Rafal and Al Shaqsi, Sultan},
title = {Paying the Price for Beauty Abroad: Khoula Hospital’s experience with complications following aesthetic procedures performed overseas, 2013–2023},
journal = {Sultan Qaboos University Medical Journal},
year = {2026},
volume = {26},
number = {1},
pages = {121--128},
doi = {10.18295/2075-0528.2965}
}
EUVIMED